The Tale of TILs in Breast Cancer: A Report from the International Immuno-Oncology Biomarker Working Group

The authors discuss the biological understanding of tumor-infiltrating lymphocytes (TILs), their analytical and clinical validity and efforts towards the clinical utility in breast cancer, and the current status of programmed death-ligand 1and TIL testing across different continents.